Nebraska Oncology Society
Nebraska Oncology Society is a non-profit organization that has been in existence since 1992. Our mission is to facilitate and promote interaction among the oncology community to enhance patient care through oncology research, education, and health care legislation.
https://www.nebraskaoncology.org/
https://www.nebraskaoncology.org/
2024 Annual Midwest Regional Mid-Year Review
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Updates on Metastatic ALK+ NSCLC
FEATURING
Vincent Lam
- 73 views
- September 11, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Local Consolidative Therapy for Oligometastatic NSCLC
FEATURING
Vincent Lam
- 43 views
- September 11, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Updates on Unresectable Malignant Pleural Mesothelioma
FEATURING
Vincent Lam
- 33 views
- September 11, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Updates on Metastatic HNSCC
FEATURING
Eric Sherman
- 146 views
- August 20, 2024
- 1
Nebraska Oncology Society
ASCO® 2024 Review: Updates on Nasopharynx Cancer
FEATURING
Eric Sherman
- 78 views
- August 13, 2024
Nebraska Oncology Society
Recent Updates in the Treatment Landscape for Advanced HCC
FEATURING
Rachael Safyan
- 36 views
- August 13, 2024
Nebraska Oncology Society
Recent Updates on the Use of MRD-Guided Strategies in Early Colon Cancer
FEATURING
Rachael Safyan
- 51 views
- August 13, 2024
Nebraska Oncology Society
Managing MSI-H/dMMR mCRC and Resectable/Unresectable Liver-Only Metastases
FEATURING
Rachael Safyan
- 70 views
- August 13, 2024
- 1
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Updates on Locally Advanced EGFR-Mutated NSCLC
FEATURING
Vincent Lam
- 28 views
- August 13, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Updates on Locally Advanced HNSCC
FEATURING
Eric Sherman
- 153 views
- August 2, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Practice-Changing Developments in LS-SCLC and ES-SCLC
FEATURING
Vincent Lam
- 172 views
- August 2, 2024
Nebraska Oncology Society
Updates on Advances in the Treatment of Newly Diagnosed Myeloma
FEATURING
Ravi Vij
- 81 views
- August 1, 2024
- 2
Nebraska Oncology Society
Updates on Advances in the Treatment R/R Myeloma
FEATURING
Ravi Vij
- 71 views
- August 1, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Metastatic Bladder Cancer Treated with EV + Pembro & Impact of PRO From EV-302
FEATURING
Nataliya Mar
- 57 views
- July 30, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Options for Non-Metastatic MIBC
FEATURING
Nataliya Mar
- 143 views
- July 30, 2024
Nebraska Oncology Society
Updates on Treatment Options for mCRPC
FEATURING
Nataliya Mar
- 119 views
- July 30, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Updates on Treatment Options for Penile Cancer
FEATURING
Nataliya Mar
- 122 views
- July 30, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Updates in the Management of Resectable Esophageal Adenocarcinoma
FEATURING
Rachael Safyan
- 94 views
- July 29, 2024
- 1
Nebraska Oncology Society
ASCO® 2024 Review: Clinically-Impactful Abstracts in Pancreatic Cancer
FEATURING
Rachael Safyan
- 51 views
- July 29, 2024